Through the correlation analysis, we found that the overexpression of CTPS2 was associated with 11q deletion and the lack of IGHV mutation, which were indicators of inferior prognosis in CLL patients. Here, CTPS2 is linked to B-cell chronic lymphocytic leukemia.